Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02783053Completed
Open-label trial of metformin in obesity, sponsored by University of Amsterdam. Primary endpoint: 18F-FDG uptake in the colon at 1 week. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02783053.